VALVO, FRANCESCA
VALVO, FRANCESCA
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300
2021 G. Marvaso, B. Vischioni, M. Pepa, M. Zaffaroni, S. Volpe, F. Patti, F. Bellerba, S. Gandini, S. Comi, G. Corrao, D. Zerini, M. Augugliaro, C. Fodor, S. Russo, S. Molinelli, M. Ciocca, R. Ricotti, F. Valvo, T. Giandini, B. Avuzzi, R. Valdagni, O. De Cobelli, F. Cattani, E. Orlandi, B.A. Jereczek-Fossa, R. Orecchia
Peri-operative prognostic factors for primary skull base chordomas : results from a single-center cohort
2020 E. La Corte, M. Broggi, A. Raggi, S. Schiavolin, F. Acerbi, G. Danesi, M. Farinotti, G. Felisati, A. Maccari, B. Pollo, M. Saini, C. Toppo, F. Valvo, R. Ghidoni, M.G. Bruzzone, F. Dimeco, P. Ferroli
Mixed-beam approach for high-risk prostate cancer : Carbon-ion boost followed by photon intensity-modulated radiotherapy. Dosimetric and geometric evaluations (AIRC IG-14300)
2020 S.G. Gugliandolo, G. Marvaso, S. Comi, M. Pepa, C. Romano, D. Zerini, M. Augugliaro, S. Russo, B. Vischioni, F. Valvo, T. Giandini, B. Avuzzi, R. Valdagni, D. Ciardo, O. De Cobelli, B.A. Jereczek-Fossa, F. Cattani, R. Orecchia
Hadrontherapy from the Italian Radiation Oncologist point of view: face the reality. The Italian Society of Oncological Radiotherapy (AIRO) survey
2017 G. Marvaso, B. Vischioni, B.A. Jereczek-Fossa, D. Ciardo, P. Fossati, T. Giandini, S. Morlino, M. Carrara, P. Romanelli, E. Russi, F. Valvo, R. Valdagni, R. Orecchia
Chronomodulated capecitabine and adjuvant radiation in intermediate-risk to high-risk rectal cancer : a phase II study
2014 E. Bajetta, F. Pietrantonio, R. Buzzoni, E. Ferrario, F. Valvo, L. Mariani, K.F. Dotti, P. Biondani, B. Formisano, A. Gevorgyan, P. Grassi, M. Di Bartolomeo
Daily sodium butyrate enema for the prevention of radiation proctitis in prostate cancer patients undergoing radical radiation therapy : Results of a multicenter randomized placebo-controlled dose-finding phase 2 study
2014 A. Maggio, A. Magli, T. Rancati, C. Fiorino, F. Valvo, G. Fellin, U. Ricardi, F. Munoz, D. Cosentino, L.F. Cazzaniga, R. Valdagni, V. Vavassori
Role of BAX for outcome prediction in gastrointestinal malignancies
2013 F. Pietrantonio, P. Biondani, E. Ciurlia, G. Fanetti, A. Tessari, G. Bertarelli, I. Bossi, V. Musella, F. Melotti, M.D. Bartolomeo, F. Valvo, A. Pellegrinelli, M. Milione, F. Perrone, F. De Braud
Primary chemotherapy in resectable oral cavity squamous cell cancer : a randomized controlled trial
2003 L. Licitra, C. Grandi, M. Guzzo, L. Mariani, S. Lo Vullo, F. Valvo, P. Quattrone, P. Valagussa, G. Bonadonna, R. Molinari, G. Cantù